Developing dietary curcumin mono-carbonyl piperidinone analogs as Nrf2-dependent cytoprotectors against oxidative

Xue-Feng Liu1, Qi Wang2, Jia-Fang Zheng2

  • 1State Key Laboratory of Applied Organic Chemistry, Lanzhou University, 222 Tianshui Street S., Lanzhou, Gansu, 730000, China; School of Pharmacy, Lanzhou University, 222 Tianshui Street S., Lanzhou, Gansu, 730000, China; College of Pharmacy, Gansu University of Traditional Chinese Medicine, 35 Dingxi East Road, Gansu, 730000, China.

Insights

Researchers developed novel Nrf2 activators inspired by curcumin. The lead compound, CN-2F, demonstrated superior cytoprotective effects against oxidative stress, offering a promising strategy for disease prevention.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Biochemistry

Background:

  • Oxidative stress contributes to diseases like cancer and inflammation.
  • Nuclear factor erythroid-2 related factor 2 (Nrf2) plays a crucial role in cellular defense against oxidative damage.
  • Curcumin is a known Nrf2 activator and chemopreventive agent, but more potent analogs are sought.

Purpose of the Study:

  • To design and synthesize novel Nrf2-dependent cytoprotectors with enhanced activity compared to curcumin.
  • To investigate the structure-activity relationships of curcumin-inspired mono-carbonyl piperidinone analogs.
  • To elucidate the molecular mechanisms underlying the cytoprotective effects of the lead compound.

Main Methods:

  • Design and synthesis of curcumin-inspired piperidinone analogs with varied substituents.
  • Evaluation of cytoprotective activity in HepG2 cells against tert-butyl hydroperoxide-induced oxidative damage.
  • Mechanistic studies involving Keap1 modification, Nrf2 signaling pathway activation (including JNK, ERK, p38 phosphorylation), and Nrf2 degradation inhibition.

Main Results:

  • A panel of analogs was synthesized, with the ortho-fluorine-substituted CN-2F identified as a highly promising lead molecule.
  • CN-2F exhibited significantly superior cytoprotective effects compared to curcumin in HepG2 cells.
  • CN-2F covalently modified Keap1 at Cys-151 and Cys-288, activating Nrf2 signaling and inhibiting its degradation.

Conclusions:

  • CN-2F is a potent Nrf2-dependent cytoprotector, outperforming curcumin.
  • The study reveals key structural determinants for designing effective curcumin-inspired Nrf2 activators.
  • Findings provide valuable insights for developing novel therapeutic strategies against oxidative stress-related diseases.

Related Concept Videos

Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
2.4K
Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
401
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.8K
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
353
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.2K